Role of altered signal transduction in heterotopic ossification and fibrodysplasia ossificans progressiva

Current Osteoporosis Reports

Volumn 9, Issue 2, 2011, Pages 83-88

  Shore, Eileen M ^a   Kaplan, Frederick S ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Activin A type I receptor; Activin like kinase 2; ACVR1; ALK2; BMP; BMP receptors; BMP signaling; Bone morphogenetic proteins; Endochondral ossification; Extraskeletal bone formation; Fibrodysplasia ossificans progressiva; FOP; Heterotopic ossification

Indexed keywords

ACTIVIN LIKE KINASE 2; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; UNCLASSIFIED DRUG;

ACVR1 GENE; ALK2 GENE; ARTICLE; BONE DEVELOPMENT; BONE REMODELING; CELL FATE; ENCHONDRAL OSSIFICATION; GENE; GENE MUTATION; HETEROTOPIC OSSIFICATION; HUMAN; NONHUMAN; OSSIFYING MYOSITIS; PATHOPHYSIOLOGY; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEM CELL;

ACTIVIN RECEPTORS, TYPE I; HUMANS; MUTATION; MYOSITIS OSSIFICANS; OSSIFICATION, HETEROTOPIC; SIGNAL TRANSDUCTION;

EID: 79957466350     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-011-0046-3     Document Type: Article

References (50)

1. Yang Y. Skeletal morphogenesis and embryonic development. In: Rosen CJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. Washington, DC: American Society of Bone and Mineral Research; 2008. p. 2-10.
2. EF McCarthy M Sundaram 2005 Heterotopic ossification: a review Skeletal Radiol 34 609 619 16132978 10.1007/s00256-005-0958-z 1:STN:280: DC%2BD28%2Fhs1yjtw%3D%3D (Pubitemid 41440002)
3. RJ Pignolo KL Foley 2005 Nonhereditary heterotopic ossification Clin Rev Bone Miner Metab 3 261 266 10.1385/BMM:3:3-4:261 (Pubitemid 41400347)
4. JA Forsberg JM Pepek S Wagner, et al. 2009 Heterotopic ossification in high-energy wartime extremity injuries: prevalence and risk factors J Bone Joint Surg Am 91 1084 1091 19411456 10.2106/JBJS.H.00792
5. B Neal H Gray S MacMahon L Dunn 2002 Incidence of heterotopic bone formation after major hip surgery ANZ J Surg 72 808 821 12437693 10.1046/j.1445-2197.2002.02549.x (Pubitemid 35370622)
6. AA van Kuijk ACH Geurts HJM van Kuppevelt 2002 Neurogenic heterotopic ossification in spinal cord injury Spinal Cord 40 313 326 12080459 10.1038/sj.sc.3101309 (Pubitemid 34756209)
7. ER Mohler 3rd F Gannon C Reynolds, et al. 2001 Bone formation and inflammation in cardiac valves Circulation 103 1522 1528 11257079 (Pubitemid 32226259)
8. J Chalmers DH Gray J Rush 1975 Observations on induction of bone in soft-tissues J Bone Jt Surg Br Vol B 57 36 45 1:STN:280:DyaE2M7hsV2rtw%3D%3D
9. EM Shore FS Kaplan 2010 Inherited human diseases of heterotopic bone formation Nat Rev Rheumatol 6 518 527 20703219 10.1038/nrrheum.2010.122 1:CAS:528:DC%2BC3cXhtV2is77M This recent review provides an overview of POH and FOP, two human genetic disorders of HO
10. FS Kaplan DL Glaser EM Shore, et al. 2005 The phenotype of fibrodysplasia ossificans progressiva Clin Rev Bone Miner Metab 3 183 188 10.1385/BMM:3:3-4: 183 (Pubitemid 41400332)
11. FS Kaplan M Le Merrer DL Glaser, et al. 2008 Fibrodysplasia ossificans progressiva Best Pract Res Clin Rheumatol 22 191 205 18328989 10.1016/j.berh.2007.11.007 1:CAS:528:DC%2BD1cXjtVWgsLc%3D (Pubitemid 351325734)
12. EM Shore FS Kaplan 2005 Fibrodysplasia ossificans progressiva and progressive osseous heteroplasia: two genetic disorders of heterotopic ossification Clin Rev Bone Miner Metab 3 257 259 10.1385/BMM:3:3-4:257 (Pubitemid 41400346)
13. Kaplan FS, Groppe JC, Seeman P, et al. Fibrodysplasia ossificans progressiva: developmental implications of a novel metamorphogene. In: Bronner F, Farach-Carson MC, Roach HI, editors. Bone and development. London: Springer-Verlag; 2010. p. 233-49.
14. FS Kaplan M Xu P Seemann, et al. 2009 Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1 Hum Mutat 30 379 390 19085907 10.1002/humu.20868 1:CAS:528:DC%2BD1MXktFCms7w%3D A series of atypical FOP clinical phenotypes and the identification of non-R206H ACVR1 mutations in these patients are reported
15. EM Shore MQ Xu GJ Feldman, et al. 2006 A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva Nat Genet 38 525 527 16642017 10.1038/ng1783 1:CAS:528: DC%2BD28XjvVGktrk%3D This first report of ACVR1/ALK2 mutations in FOP identified the ACVR1 R206H mutation as recurrent in patients with a classic clinical presentation
16. MR Urist 1965 Bone: formation by autoinduction Science 150 893 899 5319761 10.1126/science.150.3698.893 1:STN:280:DyaF28%2FhvFekuw%3D%3D
17. PC Billings JL Fiori JL Bentwood, et al. 2008 Dysregulated BMP signaling and enhanced osteogenic differentiation of connective tissue progenitor cells from patients with fibrodysplasia ossificans progressiva (FOP) J Bone Miner Res 23 305 313 17967130 10.1359/jbmr.071030 1:CAS:528:DC%2BD1cXjsl2itLg%3D (Pubitemid 351304661)
18. JL Fiori PC Billings LS Serrano de la Pena, et al. 2006 Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP) J Bone Miner Res 21 902 909 16753021 10.1359/jbmr.060215 1:CAS:528:DC%2BD28XlvVamurg%3D (Pubitemid 43787997)
19. LS Serrano de la Pena PC Billings JL Fiori, et al. 2005 Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA J Bone Miner Res 20 1168 1176 10.1359/JBMR.050305 1:CAS:528:DC%2BD2MXmsFyitL4%3D (Pubitemid 40863804)
20. AB Shafritz EM Shore FH Gannon, et al. 1996 Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva N Engl J Med 335 555 561 8678932 10.1056/NEJM199608223350804 1:CAS:528:DyaK28Xlslymtro%3D (Pubitemid 26272310)
21. R Derynck YE Zhang 2003 Smad-dependent and Smad-independent pathways in TGF-beta family signalling Nature 425 577 584 14534577 10.1038/nature02006 1:CAS:528:DC%2BD3sXnvV2hs7c%3D (Pubitemid 37280136)
22. B Schmierer CS Hill 2007 TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility Nat Rev Mol Cell Biol 8 970 982 18000526 10.1038/nrm2297 1:CAS:528:DC%2BD2sXhtlCrsb3K (Pubitemid 350174642)
23. Y Shi J Massague 2003 Mechanisms of TGF-beta signaling from cell membrane to the nucleus Cell 113 685 700 12809600 10.1016/S0092-8674(03)00432-X 1:CAS:528:DC%2BD3sXkvVekt7o%3D (Pubitemid 36724933)
24. X Guo X-F Wang 2009 Signaling cross-talk between TGF-beta/BMP and other pathways Cell Res 19 71 88 19002158 10.1038/cr.2008.302 1:CAS:528: DC%2BD1MXht1GgsQ%3D%3D
25. R Derynck RJ Akhurst 2007 Differentiation plasticity regulated by TGF-beta family proteins in development and disease Nat Cell Biol 9 1000 1004 17762890 10.1038/ncb434 1:CAS:528:DC%2BD2sXpslGju7k%3D (Pubitemid 47338137)
26. E Eivers LC Fuentealba EM De Robertis 2008 Integrating positional information at the level of Smad1/5/8 Curr Opin Genet Dev 18 304 310 18590818 10.1016/j.gde.2008.06.001 1:CAS:528:DC%2BD1cXht1KmtbfM
27. T Watabe K Miyazono 2009 Roles of TGF-beta family signaling in stem cell renewal and differentiation Cell Res 19 103 115 19114993 10.1038/cr.2008.323 1:CAS:528:DC%2BD1MXht1Ggsg%3D%3D
28. MY Wu CS Hill 2009 Tgf-beta superfamily signaling in embryonic development and homeostasis Dev Cell 16 329 343 19289080 10.1016/j.devcel.2009. 02.012 1:CAS:528:DC%2BD1MXjs1ygu7k%3D
29. J Xu S Lamouille R Derynck 2009 TGF-beta-induced epithelial to mesenchymal transition Cell Res 19 156 172 19153598 10.1038/cr.2009.5 1:CAS:528:DC%2BD1MXht1amsL4%3D
30. PB Yu DY Deng CS Lai, et al. 2008 BMP type I receptor inhibition reduces heterotopic ossification Nat Med 14 1363 1369 19029982 10.1038/nm.1888 1:CAS:528:DC%2BD1cXhsVWhu7nM
31. D Zhang EM Schwarz RN Rosier, et al. 2003 ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development J Bone Miner Res 18 1593 1604 12968668 10.1359/jbmr.2003.18.9.1593 1:CAS:528:DC%2BD3sXnsVymu74%3D (Pubitemid 37022917)
32. R Bocciardi D Bordo M Di Duca, et al. 2009 Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements Eur J Hum Genet 17 311 318 18830232 10.1038/ejhg.2008.178 1:CAS:528:DC%2BD1MXit1WktLk%3D
33. JC Groppe EM Shore FS Kaplan 2007 Functional modeling of the ACVR1 (R206H) mutation in FOP Clin Orthop Relat Res 462 87 92 17572636 10.1097/BLO.0b013e318126c049 (Pubitemid 47367848)
34. Petrie KA, Lee WH, Bullock AN, et al.: Novel mutations in ACVR1 result in atypical features in two fibrodysplasia ossificans progressiva patients. Plos One. 2009:4.
35. T Fukuda M Kohda K Kanomata, et al. 2009 Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva J Biol Chem 284 7149 7156 18684712 10.1074/jbc.M801681200 1:CAS:528:DC%2BD1MXislWqs7Y%3D
36. Q Shen SC Little M Xu, et al. 2009 The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization J Clin Invest 119 3462 3472 19855136 1:CAS:528:DC%2BD1MXhtlOitrbL In vitro and in vivo assays demonstrated ligand-independent and -responsive activation of the mutant ACVR1/ALK2 R206H receptor
37. GA Song HJ Kim KM Woo, et al. 2010 Molecular consequences of the ACVR1(R206H) mutation of fibrodysplasia ossificans progressiva J Biol Chem 285 22542 22553 20463014 10.1074/jbc.M109.094557 1:CAS:528:DC%2BC3cXos1WntL0%3D
38. M van Dinther N Visser DJJ de Gorter, et al. 2010 ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the bmp type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation J Bone Miner Res 25 1208 1215 19929436
39. M Huse TW Muir L Xu, et al. 2001 The TGF beta receptor activation process: an inhibitor- to substrate-binding switch Mol Cell 8 671 682 11583628 10.1016/S1097-2765(01)00332-X 1:CAS:528:DC%2BD3MXnslGmt7w%3D (Pubitemid 32946943)
40. FH Gannon BA Valentine EM Shore, et al. 1998 Acute lymphocytic infiltration in an extremely early lesion of fibrodysplasia ossificans progressiva Clin Orthop Relat Res 346 19 25 9577406 10.1097/00003086-199801000- 00005 (Pubitemid 28046863)
41. DL Glaser AN Economides LL Wang, et al. 2003 In vivo somatic cell gene transfer of an engineered noggin mutein prevents BMP4-induced heterotopic ossification J Bone Joint Surg Am 85A 2332 2342 (Pubitemid 37499642)
42. L Hegyi FH Gannon DL Glaser, et al. 2003 Stromal cells of fibrodysplasia ossificans progressiva lesions express smooth muscle lineage markers and the osteogenic transcription factor Runx2/Cbfa-1: clues to a vascular origin of heterotopic ossification? J Pathol 201 141 148 12950027 10.1002/path.1413 1:CAS:528:DC%2BD3sXotFyqsLk%3D (Pubitemid 37121213)
43. FS Kaplan EM Shore R Gupta, et al. 2005 Immunological features of fibrodysplasia ossificans progessiva and the dysregulated BMP4 pathway Clin Rev Bone Miner Metab 3 189 193 10.1385/BMM:3:3-4:189 (Pubitemid 41400333)
44. FS Kaplan JA Tabas FH Gannon, et al. 1993 The histopathology of fibrodysplasia ossificans progressiva An endochondral process J Bone Joint Surg Am 75 220 230 7678595 1:STN:280:DyaK3s7jvFWjsQ%3D%3D (Pubitemid 23093972)
45. RJ Pignolo RK Suda FS Kaplan 2005 The fibrodysplasia ossificans progressiva lesion Clin Rev Bone Miner Metab 3 195 200 10.1385/BMM:3:3-4:195 (Pubitemid 41400334)
46. E Olmsted-Davis FH Gannon M Ozen, et al. 2007 Hypoxic adipocytes pattern early heterotopic bone formation Am J Pathol 170 620 632 17255330 10.2353/ajpath.2007.060692 1:CAS:528:DC%2BD2sXitlOltrc%3D (Pubitemid 47339399)
47. H Wang EM Shore FS Kaplan, et al. 2008 Hypoxia promotes ligand-independent activation of the ACVR1 (R206H) mutant receptor in C2C12 cells J Bone Miner Res 23 S433 S433
48. FS Kaplan DL Glaser EM Shore, et al. 2007 Hematopoietic stem-cell contribution to ectopic skeletogenesis J Bone Joint Surg Am 89A 347 357 10.2106/JBJS.F.00472 (Pubitemid 46214354)
49. VY Lounev R Ramachandran MN Wosczyna, et al. 2009 Identification of progenitor cells that contribute to heterotopic skeletogenesis J Bone Joint Surg Am 91 652 663 19255227 10.2106/JBJS.H.01177
50. D Medici EM Shore VY Lounev, et al. 2010 Conversion of vascular endothelial cells into multipotent stem-like cells Nat Med 16 1400 1406 21102460 10.1038/nm.2252 1:CAS:528:DC%2BC3cXhsVGhsr%2FE